tiprankstipranks
pc:cambi

Cambium Biomaterials Inc

Cambium develops next-generation advanced materials for defense and high-performance industries, combining AI-driven molecular design with chemical informatics and high-performance computing to design novel monomers and polymers. The company operates proprietary manufacturing and testing assets across the U.S., the U.K., and Europe to rapidly prototype, qualify, and scale materials for aerospace, defense, energy, marine, and motorsport applications.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$100M
Total Amount Raised$100M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$100M
Latest Funding Amount$100M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 05, 2026
Series B
$100.00M

Investors

Investor Name
Funding Round

Related News and Analysis